Startseite Serum tumor marker carbohydrate antigen 125 levels and carotid atherosclerosis in patients with coronary artery disease
Artikel Open Access

Serum tumor marker carbohydrate antigen 125 levels and carotid atherosclerosis in patients with coronary artery disease

  • Guo-Yao Sang , Zhao-Yun Chen , Cun-Ren Meng , Tian Tian und Zhao-Xia Zhang EMAIL logo
Veröffentlicht/Copyright: 24. Dezember 2018

Abstract

Objective

We assessed the correlation between serum carbohydrate antigen 125 (CA125) and carotid intima-media thickness (cIMT) in patients with coronary artery disease (CAD).

Methods

We collected 518 CAD patients from the cardiovascular disease center in our hospital, and all cIMT values were measured in patients with CAD.

Results

The serum CA125 concentrations were found to be increased in CAD patients with early carotid atherosclerosis compared with patients without early carotid atherosclerosis (20.1±7.72 vs. 17.7±6.41 U/mL, p<0.001). The cIMT values were increased in patients with higher serum CA-125 levels than those with lower serum CA-125 concentrations (1.16±0.32 vs. 0.98±0.29 mm, p<0.001). There was a positive correlation between serum CA125 and cIMT in CAD patients (r=0.262, p<0.001). Moreover, the serum CA125 concentrations also were positively correlated with cIMT in subjects with early carotid atherosclerosis and without early carotid atherosclerosis (r=0.255, p<0.001; r=0.189, p=0.002). We found that serum CA-125 concentrations were independently correlated with cIMT (beta = 0.293, p<0.001) in multiple linear regression analysis.

Conclusions

We found that serum CA125 concentrations were positively correlated with cIMT in CAD patients, serum CA125 might be a potential biochemical marker for the estimation of atherosclerosis in patients with CAD.

Serum carbohydrate antigen 125 (CA125) is a molecular-weight glycoprotein manufactured by mesothelial cells and the coelomic epithelium, and it is used as a tumor marker in patients with ovarian cancer [1]. Some studies have confirmed that increased serum CA125 concentrations were related with poor prognosis in patients with ovarian cancer [2]. Serum CA125 levels were higher in other malignancies such as melanoma, non-Hodgkin’s lymphoma and acute leukemia [3, 4, 5]. Moreover, increased CA125 concentrations have been reported in patients with non-malignant diseases including nephrotic syndrome, liver cirrhosis and pelvic inflammatory disease [6, 7, 8]. Recent studies have showed that serum CA125 levels were increased in chronic heart failure patients [9]. Recently, CA125 has been considered as a tool for risk stratification in heart diseases [10], and increased serum CA125 concentrations have been found to be correlated with cardiac function in patients with coronary artery disease (CAD) [11].

It is well known that atherosclerosis is implicated in the pathogenesis and development of CAD, and atherosclerosis is the complex process of inflammation and oxidative stress [12, 13]. Carotid intima-media thickness (cIMT) is a non-invasive marker for patients with early atherosclerosis [14]. Clinical application of cIMT may provide a prediction for CAD and stroke in large-scale general population studies [15, 16], and increased cIMT values are associated with poor prognosis in patients with CAD [17]. In fact, inflammation and oxidative stress may accelerate the development of atherosclerosis, even in the general population [18]. Further, the increase in serum CA125 is correlated with the inflammatory and oxidative stress stimulation. Therefore, we assessed the correlation between serum CA125 and cIMT in patients with CAD.

1 Materials and methods

We collected 518 CAD patients from the cardiovascular disease center in the First Affiliated Hospital, Xinjiang Medical University. The diagnosis of CAD was determined by coronary angiography in all patients. Patients with following conditions were excluded: liver dysfunction, chronic obstructive pulmonary disease, aortic dissection, immune diseases, acute and chronic infections, malignant tumor and psychosis. All the subjects completed the clinical examinations, including anthropometric assessments, carotid ultrasonography examinations and laboratory tests. The study was approved by the ethics committee of the First Affiliated Hospital, Xinjiang Medical University.

We collected information about physical examinations such as age, gender, body mass index (BMI) and drug use histories. Fast plasma glucose (FPG), total protein (TP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglyceride (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) levels were tested by using automatic biochemistry analyzer. High-sensitivity C-reactive protein (hs-CRP) concentrations were tested by automatic immune analyzer. In addition, serum CA125 levels were measured with chemiluminescent analyzer. The cIMT values were obtained from ultrasonic examination results.

2 Statistics analysis

The data analyses were performed by using 19.0 SPSS software (SPSS Inc., Chicago, IL, USA). Continuous variables and categorical variables were presented as mean± standard deviation and proportions, repectively. Differences between two groups were analyzed by using the Student’s t test, U test and Chi-square test. The correlation between CA-125 and cIMT in patients CAD was analyzed by Pearson or Spearman method. Multivariate linear regression was used to further evaluate this link between CA125 and cIMT. P values of less than 0.05 were accepted as significant.

3 Results

3.1 The clinical characteristics in all patients with CAD

The study population consisted of 518 patients with CAD. The mean cIMT values were 1.1±0.31 mm. Further, when the concentrations of serum CA 125 were divided by the median, the cIMT values were increased in patients with higher serum CA-125 levels than those with lower serum CA-125 concentrations (1.16±0.32 vs. 0.98±0.29 mm, p<0.001).

3.2 The serum CA125 concentrations divided by the threshold of cIMT values

We decided to divide all patients with CAD into two groups: subjects with early carotid atherosclerosis (cIMT > 1.0 mm) and without early carotid atherosclerosis (cIMT ≤ 1.0 mm). The serum CA125 concentrations were found to be increased in CAD patients with early carotid atherosclerosis compared with patients without early carotid atherosclerosis (20.1±7.72 vs. 17.7±6.41 U/mL, p<0.001). There were statistical differences for age, body mass index, diabetes mellitus, anti-platelet agent use and high-sensitivity C-reactive protein, as shown in Table 1.

Table 1

Clinical and laboratory parameters in with and without early carotid atherosclerosis

>1.0≤1.0p-values
N=262N=256
Gender (M)222(84.7%)203(79.3%)0.107
Age(yr)55.8±13.0748.5±8.96<0.001
Body mass index (kg/m2)23.9±3.0123.1±2.800.009
Diabetes mellitus102(38.9%)75(29.3%)0.021
Hypertension116(44.3%)103(40.2%)0.352
Calcium channel blockers27(10.3%)16(6.2%)0.094
Anti-platelet agent use259(98.9%)239(93.4%)0.001
Nitrates156(59.5%)164(64.1%)0.290
B-blockers213(81.3%)195(76.2%)0.154
ACEI/ARB223(85.1%)225(87.9%)0.355
Alanine transaminase (U/L)17.4±7.8116.6±7.320.256
Aspartate transaminase (U/L)18.0±4.5517.9±4.830.772
Low density lipoprotein cholesterol (mmol/L)2.5±0.872.5±0.840.471
High density lipoprotein cholesterol (mmol/L)1.2±0.321.2±0.340.796
Total cholesterol (mmol/L)4.1±1.124.0±1.010.318
Triglycerides (mmol/L)1.0±0.331.0±0.370.348
Blood glucose (mmol/L)5.6±2.065.4±1.880.244
High-sensitivity C-reactive protein (mg/L)1.8±1.741.5±1.490.025
Creatinine (umol/L)64.6±17.2265.0±17.200.803
Serum carbohydrate antigen 125 (U/mL)20.1±7.7217.7±6.41<0.001

3.3 The correlation analysis between serum CA125 and laboratory indexes

The correlation analysis showed that serum CA125 concentrations were positively correlated with BMI, LDL-C, Cr and hs-CRP in patients with CAD (r=0.113, p=0.010; r=0.095, p=0.031; r=0.098, p=0.026; r=0.124, p=0.005) (Table 2). There was a positive correlation between serum CA125 and cIMT in CAD patients (r=0.262, p<0.001) (Figure 1). Moreover, we assessed the correlations between serum CA125 and cIMT in subjects with early carotid atherosclerosis and without early carotid atherosclerosis, the serum CA125 concentrations also were positively correlated with cIMT in the two groups (r=0.255, p<0.001; r=0.189, p=0.002).

Figure 1 Serum CA 125 concentrations and cIMT in the patients with CAD
Figure 1

Serum CA 125 concentrations and cIMT in the patients with CAD

Table 2

The correlation between serum CA125 and laboratory parameters in all patients

Itemsrp-values
Body mass index0.1130.010
High sensitivity C-reactive protein0.1240.005
Low-density lipoprotein cholesterol0.0950.031
Creatinine0.0980.026
Carotid intima-media thickness0.262<0.001

3.4 Multiple linear regression analysis between serum CA125 and cIMT in all patients

In the multiple linear regression analysis, adjustment for sex, age, BMI, blood glucose, LDL-C,HDL-C, TC, TG, hs-CRP, ALT, AST, diabetes mellitus, hypertension and medications uses, we found that serum CA-125 concentrations were independently correlated with cIMT (beta = 0.293, p<0.001) in multiple linear regression analysis (Table 3). The correlation between serum CA-125 and cIMT in all patients with CAD reappeared when cIMT variable was included in dependent variable in the multiple linear regression analysis (beta=0.258, p<0.001) (Table 4).

Table 3

Serum carbohydrate antigen 125 as dependent variable in multivariable linear regression analysis

Unstandardized cofficientsStandardized cofficientstP-value
BStd ErrorBeta
Creatinine0.0570.0180.1363.2280.001
High sensitivity C-reactive protein0.4400.1900.0992.3120.021
Carotid intima-media thicknes6.7080.9910.2936.773<0.001
Table 4

Carotid intima-media thickness as dependent variable in multivariable linear regression analysis

Unstandardized cofficientsStandardized cofficientstP-value
BStd ErrorBeta
Age0.0080.0010.2897.204<0.001
Body mass index0.0150.0040.1403.516<0.001
Blood glucose0.0200.0060.1233.0990.002
Triglycerides0.0800.0360.0892.2380.026
Serum carbohydrate antigen 1250.0110.0020.2586.496<0.001

4 Discussion

The cIMT measurements have been recommended as a screening method for high-risk populations with cardiovascular events such as older adults, type 2 diabetes mellitus and systemic lupus erythematosus [19, 20, 21]. There was evidence that cIMT is an independent predictor of stroke in persons without a hi story of cardiovascular disease [22]. In addition, serum CA125 has been associated with the diagnosis and prognosis of tumor diseases such as ovarian cancer [1], variant prostate carcinoma [3], non-Hodgkin’s lymphoma [23]. Interestingly, our study

first found that the increased serum CA125 concentrations were positively correlated with cIMT in the study population, and serum CA125 may be a well marker for subclinical atherosclerosis in patients with CAD. However the mechanism for the correlation between serum CA-125 concentrations and cIMT still remains unclear. Inflammation may contribute to explain this relationship. It is known that the atherosclerosis is considered to be the accumulation of lipoproteins and the stimulation of inflammation in the arterial wall, and low-density lipoprotein molecules are the main inducement for the pathological processes [24]. Indeed, the inflammation plays a key role in the regulation of the atherosclerotic development. Some studies have shown that some inflammatory cytokines were related with carotid atherosclerosis [25]. The production of CRP has been found to promote the formation of atherosclerosis directly [26]. Recent studies have found that serum CA125 concentrations were related to inflammatory cytokines in patients with heart failure and atrial fibrillation, such as interleukin-6 (IL-6), interleukin-1 (IL-1) and tumor necrosis factor-α (TNF-α), and increased CA125 levels might be the activation of inflammatory cytokines in the early stages of atherosclerosis [9, 27-28]. Therefore, the inflammatory conditions may increase serum CA125 concentrations in patients with CAD, and links the relationship between serum CA125 and cIMT in study subjects.

The screening and detection of subclinical atherosclerosis is a primary prevention, which can reduce the occurrence of cardiovascular events. Compared with carotid ultrasound, serum CA125 is an objective and convenient biochemical parameter, which is rarely affected by subjective factors. In our study, we found correlation between serum CA125 and cIMT in patients with CAD. Therefore, we believe that serum CA125 may provide useful information for the assessment of atherosclerosis in patients with CAD.

We noted several limitations in this study. First, a longitudinal study is needed to assess the relationship between serum CA125 and cIMT in patients with CAD. Second, our study did not assess the link of serum CA125 and clinical outcomes in patients with CAD. Finally, the present study did not provide the evidence between serum CA125 and anti-inflammatory treatments in patients with CAD. In conclusion, we found that serum CA125 concentrations were positively correlated with cIMT in CAD patients, and serum CA-125 may be a potential biochemical marker for the atherosclerosis in patients with CAD.

  1. Interest declarations: The authors have no financial conflicts of interes

References

[1] van der Burg ME, Lammes FB, Verweij J. Canc CA 125 in ovarian cancer. Neth J Med. 1992 Feb; 40(1-2):36-51Suche in Google Scholar

[2] Moss EL, Hollingworth J, Reynolds TM. The role of CA125 in clinical practice. J Clin Pathol. 2005 Mar; 58(3):308-31210.1136/jcp.2004.018077Suche in Google Scholar

[3] Erdile LF, Smith D, Berd D. Whole cell ELISA for detection of tumor antigen expression in tumor samples. J Immunol Methods. 2001 Dec 1;258(1-2):47-5310.1016/S0022-1759(01)00465-3Suche in Google Scholar

[4] Zacharos ID, Efstathiou SP, Petreli E, Georgiou G, Tsioulos DI, Mastorantonakis SE, Christakopoulou I, Roussou PP. The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma. Eur J Haematol. 2002 Oct;69(4):221-22610.1034/j.1600-0609.2002.02771.xSuche in Google Scholar

[5] Camera A, Villa MR, Rocco S, De Novellis T, Costantini S, Pezzullo L, Lucania A, Mariano A, Macchia V, Rotoli B. Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement. Cancer. 2000 Jan 1;88(1):75-7810.1002/(SICI)1097-0142(20000101)88:1<75::AID-CNCR11>3.0.CO;2-#Suche in Google Scholar

[6] Peng T, Guo L, Xia Q, Yang X. Clinical significance of serum CA125 in nephrotic syndrome. Clin Lab. 2012;58(1-2):113-115Suche in Google Scholar

[7] Qureshi MO, Dar FS, Khokhar N. Cancer Antigen-125 as a marker of ascites in patients with liver cirrhosis. J Coll Physicians Surg Pak. 2014 Apr;24(4):232-5. doi: 04.2014/ JCPSP.23223504.2014/JCPSP.232235Suche in Google Scholar

[8] Candocia SA, Locker GY. Elevated serum CA 125 secondary to tuberculous peritonitis. Cancer. 1993 Sep 15;72(6):2016-201810.1002/1097-0142(19930915)72:6<2016::AID-CNCR2820720637>3.0.CO;2-TSuche in Google Scholar

[9] Turgut O, Tandogan I, Yilmaz MB, Gul I, Zorlu A. CA125 in heart failure: implications for immune-inflammatory activity. Int J Cardiol. 2011 Jan 7; 146(1):99-100. doi: 10.1016/j. ijcard.2010.05.07710.1016/j.ijcard.2010.05.077Suche in Google Scholar

[10] Falcão F, de Oliveira FRA, da Silva MCFC, Sobral Filho DC. Carbohydrate antigen 125: a promising tool for risk stratification in heart diseases. Biomark Med. 2018 Apr;12(4):367-38110.2217/bmm-2017-0452Suche in Google Scholar

[11] Rong X, Yunke Z, Guoping L, Zhenyue C. Clinical and prognostic value of elevated CA125 levels in patients with coronary heart disease. Herz. 2015 Jun;40(4):690-69410.1007/s00059-014-4109-ySuche in Google Scholar

[12] Ikonomidis I, Makavos G, Lekakis J. Arterial stiffness and coronary artery disease. Curr Opin Cardiol. 2015 Jul;30(4):422-31. doi: 10.1097/HCO.000000000000017910.1097/HCO.0000000000000179Suche in Google Scholar

[13] Roger VL, Go AS, Lloyd-Jones DM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 2011; 123:e18-e209Suche in Google Scholar

[14] Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation 2007; 115: 459-46710.1161/CIRCULATIONAHA.106.628875Suche in Google Scholar PubMed

[15] Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997; 96: 1432-143710.1161/01.CIR.96.5.1432Suche in Google Scholar PubMed

[16] O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr; Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999; 340: 14-2210.1056/NEJM199901073400103Suche in Google Scholar PubMed

[17] Evensen K, Sarvari SI, Rønning OM, Edvardsen T, Russell D.Carotid artery intima-media thickness is closely related to impaired left ventricular function in patients with coronary artery disease: a single-centre, blinded, non-randomized study. Cardiovasc Ultrasound. 2014 Sep 29;12:3910.1186/1476-7120-12-39Suche in Google Scholar PubMed PubMed Central

[18] Rosvall M, Janzon L, Berglund G, Engstrôm G, Hedblad B. Incidence of stroke is related to carotid IMT even in the absence of plaque. Atherosclerosis. 2005; 179: 325-33110.1016/j.atherosclerosis.2004.10.015Suche in Google Scholar PubMed

[19] Plichart M, Celermajer DS, Zureik M, Helmer C, Jouven X, Ritchie K, Tzourio C, Ducimetière P, Empana JP. Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study. Atherosclerosis. 2011 Dec;219(2):917-24. doi: 10.1016/j.atherosclerosis.2011.09.02410.1016/j.atherosclerosis.2011.09.024Suche in Google Scholar PubMed

[20] Yeboah J, Erbel R, Delaney JC, Nance R, Guo M, Bertoni AG, Budoff M, Moebus S, Jöckel KH, Burke GL, Wong ND, Lehmann N, Herrington DM, Möhlenkamp S, Greenland P. Development of a new diabetes risk prediction tool for incident coronary heart disease events: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Atherosclerosis. 2014 Oct;236(2):411-7. doi: 10.1016/j.atherosclerosis.2014.07.03510.1016/j.atherosclerosis.2014.07.035Suche in Google Scholar PubMed PubMed Central

[21] Scalzi LV1, Bhatt S, Gilkeson RC, Shaffer ML. The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus. Lupus. 2009 Dec;18(14):1289-97. doi: 10.1177/096120330934578110.1177/0961203309345781Suche in Google Scholar PubMed PubMed Central

[22] Chien KL, Su TC, Jeng JS, Hsu HC, Chang WT, Chen MF, Lee YT, Hu FB. Carotid artery intima-media thickness, carotid plaque and coronary heart disease and stroke in Chinese. PLoS One. 2008;3(10):e3435. doi: 10.1371/journal.pone.000343510.1371/journal.pone.0003435Suche in Google Scholar PubMed PubMed Central

[23] Zacharos ID, Efstathiou SP, Petreli E, Georgiou G, Tsioulos DI, Mastorantonakis SE, Christakopoulou I, Roussou PP. The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma. Eur J Haematol. 2002 Oct;69(4):221-22610.1034/j.1600-0609.2002.02771.xSuche in Google Scholar PubMed

[24] Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res. 2009 Apr;50 Suppl:S376-81. doi: 10.1194/jlr.R800087-JLR20010.1194/jlr.R800087-JLR200Suche in Google Scholar PubMed PubMed Central

[25] Kosaka T, Kokubo Y, Ono T, Sekine S, Kida M, Kikui M, Yamamoto M, Watanabe M, Amano A, Maeda Y, Miyamoto Y. Salivary inflammatory cytokines may be novel markers of carotid atherosclerosis in a Japanese general population: the Suita study. Atherosclerosis. 2014 Nov;237(1):123-12810.1016/j.atherosclerosis.2014.08.046Suche in Google Scholar PubMed

[26] Bian F, Yang X, Zhou F, et al. C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells. Br J Pharmacol. 2014 May;171(10):2671-268410.1111/bph.12616Suche in Google Scholar PubMed PubMed Central

[27] Huang F, Chen J, Liu Y, Zhang K, Wang J, Huang H. New mechanism of elevated CA125 in heart failure: the mechanical stress and inflammatory stimuli initiate CA125 synthesis. Med Hypotheses. 2012 Sep;79(3):381-38310.1016/j.mehy.2012.05.042Suche in Google Scholar PubMed

[28] Hamdy NM. Relationship between pro-anti-inflammatory cytokines, T-cell activation and CA 125 in obese patients with heart failure. Med Sci Monit. 2011 Feb 25;17(3):CR174-17910.12659/MSM.881453Suche in Google Scholar

Received: 2018-08-01
Accepted: 2018-09-23
Published Online: 2018-12-24

© 2018 Guo-Yao Sang et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Artikel in diesem Heft

  1. Regular Articles
  2. Cleidocranial dysplasia-dental disorder treatment and audiology diagnosis
  3. A hybrid neural network – world cup optimization algorithm for melanoma detection
  4. Early administration of venovenous extracorporeal life support for status asthmaticus during anaesthetic induction: case report and literature review
  5. Assessment of maximal isometric hand grip strength in school-aged children
  6. Evaluation of a neurokinin-1 antagonist in preventing multiple-day cisplatin-induced nausea and vomiting
  7. Value of continuous video EEG and EEG responses to thermesthesia stimulation in prognosis evaluation of comatose patients after cardiopulmonary resuscitation
  8. Platelet-rich plasma protects HUVECs against oX-LDL-induced injury
  9. Pharmacoeconomics of three therapeutic schemes for anti-tuberculosis therapy induced liver injury in China
  10. Small-cell lung cancer presenting as fatal pulmonary hemorrhage
  11. Correlation of retinopathy of prematurity with bronchopulmonary dysplasia
  12. Prognosis of treatment outcomes by cognitive and physical scales
  13. The efficacy of radiofrequency hyperthermia combined with chemotherapy in the treatment of advanced ovarian cancer
  14. Arcuate Fasciculus in Autism Spectrum Disorder Toddlers with Language Regression
  15. Aesthetic dental procedures: legal and medico-legal implications
  16. Blood transfusion in children: the refusal of Jehovah’s Witness parents’
  17. Burnout among anesthetists and intensive care physicians
  18. Relationship of HS CRP and sacroiliac joint inflammation in undifferentiated spondyloarthritis
  19. Ethical and legal issues in gestational surrogacy
  20. Effects of arginine vasopressin on migration and respiratory burst activity in human leukocytes
  21. Associations of diabetic retinopathy with retinal neurodegeneration on the background of diabetes mellitus. Overview of recent medical studies with an assessment of the impact on healthcare systems
  22. Pituitary dysfunction from an unruptured ophthalmic internal carotid artery aneurysm with improved 2-year follow-up results: A case report
  23. Effectiveness of treatment with endostatin in combination with emcitabine, carboplatin, and gemcitabine in patients with advanced non-small cell lung cancer: a retrospective study
  24. Piercing and tattoos in adolescents: legal and medico-legal implications
  25. The central importance of information in cosmetic surgery and treatments
  26. Penile calciphylaxis in a patient with end-stage renal disease: a case report and review of the literature
  27. Serum CA72-4 as a biomarker in the diagnosis of colorectal cancer: A meta-analysis
  28. Association between uric acid and metabolic syndrome in elderly women
  29. Distinct expression and prognostic value of MS4A in gastric cancer
  30. MAPK pathway involved in epidermal terminal differentiation of normal human epidermal keratinocytes
  31. Association of central obesity with sex hormonebinding globulin: a cross-sectional study of 1166 Chinese men
  32. Successful endovascular therapy in an elderly patient with severe hemorrhage caused by traumatic injury
  33. Inflammatory biomarkers and risk of atherosclerotic cardiovascular disease
  34. Related factors of early mortality in young adults with cerebral hemorrhage
  35. Growth suppression of glioma cells using HDAC6 inhibitor, tubacin
  36. Post-stroke upper limb spasticity incidence for different cerebral infarction site
  37. The esophageal manometry with gas-perfused catheters
  38. MMP-2 and TIMP-2 in patients with heart failure and chronic kidney disease
  39. Genetic testing: ethical aspects
  40. Intervention for physician burnout: A systematic review
  41. The melanin-concentrating hormone system in human, rodent and avian brain
  42. Clinical effects of piribedil in adjuvant treatment of Parkinson’s Disease: A meta-analysis
  43. Identification of a novel BRAF Thr599dup mutation in lung adenocarcinoma
  44. Adrenal incidentaloma – diagnostic and treating problem – own experience
  45. Common illnesses in tropical Asia and significance of medical volunteering
  46. Genetic risk in insurance field
  47. Genetic testing and professional responsibility: the italian experience
  48. The mechanism of mitral regurgitant jets identified by 3-dimensional transesophageal echocardiography
  49. Control of blood pressure and cardiovascular outcomes in type 2 diabetes
  50. Pseudomesotheliomatous primary squamous cell lung carcinoma: The first case reported in Turkey and a review of the literature
  51. Diagnostic efficacy of serum 1,3-β-D-glucan for invasive fungal infection: An update meta-analysis based on 37 case or cohort studies
  52. GPER was associated with hypertension in post-menopausal women
  53. Metabolic activity of sulfate-reducing bacteria from rodents with colitis
  54. Association of miRNA122 & ADAM17 with lipids among hypertensives in Nigeria
  55. The efficacy and safety of enoxaparin: a meta-analysis
  56. Cuffed versus uncuffed endotracheal tubes in pediatrics: a meta-analysis
  57. Thresholding for medical image segmentation for cancer using fuzzy entropy with level set algorithm
  58. Sleep deprivation in Intensive Care Unit – systematic review
  59. Benefits of computed tomography in reducing mortality in emergency medicine
  60. Ipragliflozin ameliorates liver damage in non-alcoholic fatty liver disease
  61. Limits of professional competency in nurses working in Nicu
  62. MDA-19 suppresses progression of melanoma via inhibiting the PI3K/Akt pathway
  63. The effect of smoking on posttraumatic pseudoarthrosis healing after internal stabilization, treated with platelet rich plasma (PRP)
  64. Partial deletion of the long arm of chromosome 7: a case report
  65. Meta-analysis of PET/CT detect lymph nodes metastases of cervical cancer
  66. High Expression of NLRC5 is associated with prognosis of gastric cancer
  67. Is monitoring mean platelet volume necessary in breast cancer patients?
  68. Resectable single hepatic epithelioid hemangioendothelioma in the left lobe of the liver: a case report
  69. Epidemiological study of carbapenem-resistant Klebsiella pneumoniae
  70. The CCR5-Delta32 genetic polymorphism and HIV-1 infection susceptibility: a meta-analysis
  71. Phenotypic and molecular characterisation of Staphylococcus aureus with reduced vancomycin susceptibility derivated in vitro
  72. Preliminary results of Highly Injectable Bi-Phasic Bone Substitute (CERAMENT) in the treatment of benign bone tumors and tumor-like lesions
  73. Analysis of patient satisfaction with emergency medical services
  74. Guillain-Barré syndrome and Low back pain: two cases and literature review
  75. HELLP syndrome complicated by pulmonary edema: a case report
  76. Pharmacokinetics of vancomycin in patients with different renal function levels
  77. Recurrent chronic subdural hematoma: Report of 13 cases
  78. Is awareness enough to bring patients to colorectal screening?
  79. Serum tumor marker carbohydrate antigen 125 levels and carotid atherosclerosis in patients with coronary artery disease
  80. Plastic treatment for giant pseudocyst after incisional hernia mesh repair: a case report and comprehensive literature review
  81. High expression levels of fascin-1 protein in human gliomas and its clinical relevance
  82. Thromboembolic complications following tissue plasminogen activator therapy in patients of acute ischemic stroke - Case report and possibility for detection of cardiac thrombi
  83. The effects of gastrointestinal function on the incidence of ventilator-associated pneumonia in critically ill patients
  84. A report of chronic intestinal pseudo-obstruction related to systemic lupus erythematosus
  85. Risk model in women with ovarian cancer without mutations
  86. Direct oral anticoagulants and travel-related venous thromboembolism
  87. How bispectral index compares to spectral entropy of the EEG and A-line ARX index in the same patient
  88. Henoch-schonlein purpura nephritis with renal interstitial lesions
  89. Cardiovascular risk estimated by UKPDS risk engine algorithm in diabetes
  90. CD5 and CD43 expression are associate with poor prognosis in DLBCL patients
  91. Combination of novoseven and feiba in hemophiliac patients with inhibitors
Heruntergeladen am 21.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/med-2018-0078/html
Button zum nach oben scrollen